Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark N Polizzotto

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Plos Pathogens|March 29, 2014
Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteomeNazzarena Labo, Wendell Miley, Vickie Marshall, et al.
AIDS (London, England)|June 23, 2023
Immunophenotypic analysis in participants with Kaposi sarcoma following pomalidomide administrationKathryn Lurain, Mark N Polizzotto, Laurie T Krug, et al.
Blood|October 22, 2014
Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman diseaseThomas S Uldrick, Mark N Polizzotto, Karen Aleman, et al.
Open Forum Infectious Diseases|June 27, 2018
Inflammation Associates With Impaired Small Arterial Elasticity Early in HIV DiseaseTess E Peterson, Katherine Huppler Hullsiek, Nicole Wyman Engen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
A Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab followed by Bevacizumab Monotherapy in Patients with Advanced Kaposi SarcomaRamya Ramaswami, Thomas S Uldrick, Mark N Polizzotto, et al.
Open Forum Infectious Diseases|January 25, 2018
Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART StudyJose R Castillo-Mancilla, Andrew N Phillips, James D Neaton, et al.
BMC Public Health|January 5, 2019
HIV treatment regimens and adherence to national guidelines in Australia: an analysis of dispensing data from the Australian pharmaceutical benefits schemeNila J Dharan, Tomas Radovich, Samuel Che, et al.
AIDS Research and Human Retroviruses|December 17, 2019
Comorbidity Medications Are Dispensed to More People Receiving Antiretroviral Therapy for HIV Compared with the General Population in AustraliaNila J Dharan, Tomas Radovich, Samuel Che, et al.
Plos One|January 4, 2014
Evaluation of non-invasive multispectral imaging as a tool for measuring the effect of systemic therapy in Kaposi sarcomaJana M Kainerstorfer, Mark N Polizzotto, Thomas S Uldrick, et al.
HIV Medicine|September 29, 2021
Time trends in cancer incidence in Australian people living with HIV between 1982 and 2012Ian K J Wong, Andrew E Grulich, Isobel Mary Poynten, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Plos Pathogens|March 29, 2014
Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteomeNazzarena Labo, Wendell Miley, Vickie Marshall, et al.
AIDS (London, England)|June 23, 2023
Immunophenotypic analysis in participants with Kaposi sarcoma following pomalidomide administrationKathryn Lurain, Mark N Polizzotto, Laurie T Krug, et al.
Blood|October 22, 2014
Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman diseaseThomas S Uldrick, Mark N Polizzotto, Karen Aleman, et al.
Open Forum Infectious Diseases|June 27, 2018
Inflammation Associates With Impaired Small Arterial Elasticity Early in HIV DiseaseTess E Peterson, Katherine Huppler Hullsiek, Nicole Wyman Engen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
A Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab followed by Bevacizumab Monotherapy in Patients with Advanced Kaposi SarcomaRamya Ramaswami, Thomas S Uldrick, Mark N Polizzotto, et al.
Open Forum Infectious Diseases|January 25, 2018
Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART StudyJose R Castillo-Mancilla, Andrew N Phillips, James D Neaton, et al.
BMC Public Health|January 5, 2019
HIV treatment regimens and adherence to national guidelines in Australia: an analysis of dispensing data from the Australian pharmaceutical benefits schemeNila J Dharan, Tomas Radovich, Samuel Che, et al.
AIDS Research and Human Retroviruses|December 17, 2019
Comorbidity Medications Are Dispensed to More People Receiving Antiretroviral Therapy for HIV Compared with the General Population in AustraliaNila J Dharan, Tomas Radovich, Samuel Che, et al.
Plos One|January 4, 2014
Evaluation of non-invasive multispectral imaging as a tool for measuring the effect of systemic therapy in Kaposi sarcomaJana M Kainerstorfer, Mark N Polizzotto, Thomas S Uldrick, et al.
HIV Medicine|September 29, 2021
Time trends in cancer incidence in Australian people living with HIV between 1982 and 2012Ian K J Wong, Andrew E Grulich, Isobel Mary Poynten, et al.
Pageof 9